Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.
about
Current Chemotherapy and Potential New Targets in Uterine LeiomyosarcomaMolecular Targets and Emerging Therapeutic Options for Uterine LeiomyosarcomaManagement Strategies in Advanced Uterine Leiomyosarcoma: Focus on TrabectedinA Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: an NRG Oncology/Gynecologic Oncology Group StudyFixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II studyA retrospective study on combination therapy with ifosfamide, adriamycin and cisplatin for progressive or recurrent uterine sarcoma.A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D.Locally-advanced unresected uterine leiomyosarcoma with triple-modality treatment combining radiotherapy, chemotherapy and hyperthermia: A case report.Inhibition of uterine sarcoma cell growth through suppression of endogenous tyrosine kinase B signaling.Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma.Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).Long-term Survival in a Patient with Recurrent Pulmonary Metastases from Uterine Leiomyosarcoma.Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.The role of adjuvant therapy in uterine leiomyosarcomaOverall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma.Uterine leiomyosarcoma: 14-year two-center experience of 31 cases.Unusual presentation of retroperitoneal leiomyosarcoma mimicking an adnexal tumor with highly elevated serum CA-19-9A review of treatment of uterine leiomyosarcomas.Going further in the knowledge of Yondelis®; what's new in clinical trials?High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches.Pharmacological treatment for uterine leiomyosarcomas.Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome.Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?Epigallocatechin-3-gallate potentiates curcumin's ability to suppress uterine leiomyosarcoma cell growth and induce apoptosis.Metastatic uterine leiomyosarcoma in the upper buccal gingiva misdiagnosed as an epulis.Tumors Sharply Increased after Ceasing Pazopanib Therapy for a Patient with Advanced Uterine Leiomyosarcoma: Experience of Tumor Flare.Optimal management of uterine leiomyosarcoma.Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan.Multimodality management of leiomyosarcoma of the cervix.Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma G
P2860
Q26767435-F0E41951-62E4-4692-8072-8D7DC8B5DBFDQ28076023-F64A77BE-4E23-42A8-9887-7D7ED102563CQ28087771-64D76B5E-68B1-4C9F-A36D-8DF610180A4CQ30370631-9FDF02BC-3B6C-4316-8A58-6BC64BF64544Q30439459-6ADD34A9-6B9E-4B4C-9509-F5AF945FD52DQ33343936-AFD912CB-3E24-45C3-ABD8-11F3E6BCA804Q33379886-F6DA26FD-0A6C-41ED-9359-230CC9828F25Q33386535-45B5D510-2B6F-48D5-98BE-1299F1F4245FQ33415973-9C642C44-C307-41B1-9D2B-AEF21A958711Q33438485-9E4518D1-8BEE-4B9B-A71B-1032A765E3A2Q33844215-3AD7D16D-5008-4E72-9AB0-BFECA8CD926DQ34387629-C3537627-13B7-4F52-B828-6105E4377275Q36001482-D87095BF-12C0-491B-9DD1-31BC11976AB3Q36295510-0227DF1C-20FE-4CF6-B357-9326236709ADQ36493924-051D9134-8097-4EF2-B537-3EED74AC759EQ36795987-E7FB0E88-CC8F-47A7-851A-F8212E3FDF29Q36811788-153C1584-CD0D-417C-86D7-3C84EB2FD17CQ36995072-BE11AC66-1DB7-4410-B813-8DFE92788CEFQ37234198-7DD5744B-DC2F-4A64-A492-661301C19E9BQ37584802-0004296C-F471-40E3-9DD0-E40381135689Q38153648-0F0DD32C-4315-49A6-886E-82514F680139Q38232374-7B5A620C-4F63-4356-9D83-4FF23D32891DQ38239833-0DBA5F6B-D768-4F7F-9264-7875A2F4E628Q38270671-92368BCF-682B-418D-9B8B-D6DF800E5DFAQ38765107-2B2D99F2-53A9-42B6-A0A8-A558DF2A50DFQ38769613-790EB713-EFAC-4A85-B754-5F5E88F2A725Q39393499-E0B3B028-6FB7-4684-ADA6-E1967123EF89Q42085958-E2F759F6-D609-433F-89A6-605A5ACEC4DCQ42290997-7532662D-E69A-4EF1-AA61-82E887AC65DAQ43173702-672268AC-386A-4037-A20B-6C6AF609DC43Q54711421-C5D8A09D-0720-4901-AE96-305229B64C0AQ55328084-74082436-3E60-43EA-9629-DF2EF6725468Q57570892-C54CF582-C1C9-4EB3-83BA-ACD498355C4C
P2860
Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Ifosfamide and doxorubicin in ...... ecologic Oncology Group study.
@ast
Ifosfamide and doxorubicin in ...... ecologic Oncology Group study.
@en
type
label
Ifosfamide and doxorubicin in ...... ecologic Oncology Group study.
@ast
Ifosfamide and doxorubicin in ...... ecologic Oncology Group study.
@en
prefLabel
Ifosfamide and doxorubicin in ...... ecologic Oncology Group study.
@ast
Ifosfamide and doxorubicin in ...... ecologic Oncology Group study.
@en
P2093
P356
P1433
P1476
Ifosfamide and doxorubicin in ...... ecologic Oncology Group study.
@en
P2093
Blessing JA
Malfetano JH
P304
P356
10.1006/GYNO.1996.0220
P407
P577
1996-08-01T00:00:00Z